Patents by Inventor Henry Stern

Henry Stern has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Antagonist Antibodies Directed Against Calcitonin Gene-Related Peptide and Methods Using Same
    Publication number: 20230235032
    Abstract: The invention features methods for preventing or treating CGRP associated disorders such as vasomotor symptoms and/or headaches (e.g., migraine, cluster headache, and tension headache) by administering an anti-CGRP antagonist antibody. Compositions for use in the disclosed methods are also provided. Antagonist antibody G1 and antibodies derived from G1 directed to CGRP are also described.
    Type: Application
    Filed: July 12, 2022
    Publication date: July 27, 2023
    Inventors: Marcelo Bigal, Sarah Walter, Henry Stern, Michael Chang
  • Treating headache comprising administering an antibody to calcitonin gene-related peptide
    Patent number: 11555064
    Abstract: The invention features methods for preventing or treating CGRP associated disorders such as vasomotor symptoms and/or headaches (e.g., migraine, cluster headache, and tension headache) by administering an anti-CGRP antagonist antibody. Compositions for use in the disclosed methods are also provided. Antagonist antibody G1 and antibodies derived from G1 directed to CGRP are also described.
    Type: Grant
    Filed: November 7, 2019
    Date of Patent: January 17, 2023
    Assignee: Teva Pharmaceuticals International GmbH
    Inventors: Marcelo Bigal, Sarah Walter, Henry Stern, Michael Chang
  • Antagonist Antibodies Directed Against Calcitonin Gene-Related Peptide and Methods Using Same
    Publication number: 20200377581
    Abstract: The invention features methods for preventing or treating CGRP associated disorders such as vasomotor symptoms and/or headaches (e.g., migraine, cluster headache, and tension headache) by administering an anti-CGRP antagonist antibody. Compositions for use in the disclosed methods are also provided. Antagonist antibody G1 and antibodies derived from G1 directed to CGRP are also described.
    Type: Application
    Filed: December 12, 2019
    Publication date: December 3, 2020
    Inventors: Marcelo Bigal, Sarah Walter, Henry Stern, Michael Chang
  • Antagonist Antibodies Directed Against Calcitonin Gene-Related Peptide and Methods Using Same
    Publication number: 20200331991
    Abstract: The invention features methods for preventing or treating CGRP associated disorders such as vasomotor symptoms and/or headaches (e.g., migraine, cluster headache, and tension headache) by administering an anti-CGRP antagonist antibody. Compositions for use in the disclosed methods are also provided. Antagonist antibody G1 and antibodies derived from G1 directed to CGRP are also described.
    Type: Application
    Filed: November 7, 2019
    Publication date: October 22, 2020
    Inventors: Marcelo Bigal, Sarah Walter, Henry Stern, Michael Chang
  • Antagonist antibodies directed against calcitonin gene-related peptide and methods using same
    Patent number: 10556945
    Abstract: The invention features methods for preventing or treating CGRP associated disorders such as vasomotor symptoms and/or headaches (e.g., migraine, cluster headache, and tension headache) by administering an anti-CGRP antagonist antibody. Compositions for use in the disclosed methods are also provided. Antagonist antibody G1 and antibodies derived from G1 directed to CGRP are also described.
    Type: Grant
    Filed: May 13, 2015
    Date of Patent: February 11, 2020
    Assignee: Teva Pharmaceuticals International GmbH
    Inventors: Marcelo Bigal, Sarah Walter, Henry Stern, Michael Chang
  • Treating headache comprising administering an antibody to calcitonin gene-related peptide
    Patent number: 10519224
    Abstract: The invention features methods for preventing or treating CGRP associated disorders such as vasomotor symptoms and/or headaches (e.g., migraine, cluster headache, and tension headache) by administering an anti-CGRP antagonist antibody. Compositions for use in the disclosed methods are also provided. Antagonist antibody G1 and antibodies derived from G1 directed to CGRP are also described.
    Type: Grant
    Filed: January 25, 2018
    Date of Patent: December 31, 2019
    Assignee: Teva Pharmaceuticals International GmbH
    Inventors: Marcelo Bigal, Sarah Walter, Henry Stern, Michael Chang
  • Antagonist Antibodies Directed Against Calcitonin Gene-Related Peptide and Methods Using Same
    Publication number: 20190031745
    Abstract: The invention features methods for preventing or treating CGRP associated disorders such as vasomotor symptoms and/or headaches (e.g., migraine, cluster headache, and tension headache) by administering an anti-CGRP antagonist antibody. Compositions for use in the disclosed methods are also provided. Antagonist antibody G1 and antibodies derived from G1 directed to CGRP are also described.
    Type: Application
    Filed: January 25, 2018
    Publication date: January 31, 2019
    Inventors: Marcelo Bigal, Sarah Walter, Henry Stern, Michael Chang
  • Antagonist antibodies directed against calcitonin gene-related peptide and methods using same
    Patent number: 9896502
    Abstract: The invention features methods for preventing or treating CGRP associated disorders such as vasomotor symptoms and/or headaches (e.g., migraine, cluster headache, and tension headache) by administering an anti-CGRP antagonist antibody. Compositions for use in the disclosed methods are also provided. Antagonist antibody G1 and antibodies derived from G1 directed to CGRP are also described.
    Type: Grant
    Filed: March 20, 2015
    Date of Patent: February 20, 2018
    Assignee: Teva Pharmaceuticals International GmbH
    Inventors: Marcelo Bigal, Sarah Walter, Henry Stern, Michael Chang
  • Parallel detection of updates to a domain name system record system using a common filter
    Patent number: 9762542
    Abstract: In an embodiment, a computer-implemented method detects updates to a domain name system record system. In the method, a stream of data points is received with each data point describing a record of a domain name system. For respective data points, a processor is selected from a plurality of processors. The processors are each configured to apply a data point against a common filter that assesses whether the data point is in a set. At the selected processor, the respective data point is applied to the common filter to determine whether the record is included in the set. When the record is determined not to be included in the set, a message is provided to indicate that the domain name system includes a new record, and the common filter is updated to include the data point in the set.
    Type: Grant
    Filed: February 12, 2016
    Date of Patent: September 12, 2017
    Assignee: FARSIGHT SECURITY, INC.
    Inventor: Henry Stern
  • PARALLEL DETECTION OF UPDATES TO A DOMAIN NAME SYSTEM RECORD SYSTEM USING A COMMON FILTER
    Publication number: 20170041292
    Abstract: In an embodiment, a computer-implemented method detects updates to a domain name system record system. In the method, a stream of data points is received with each data point describing a record of a domain name system. For respective data points, a processor is selected from a plurality of processors. The processors are each configured to apply a data point against a common filter that assesses whether the data point is in a set. At the selected processor, the respective data point is applied to the common filter to determine whether the record is included in the set. When the record is determined not to be included in the set, a message is provided to indicate that the domain name system includes a new record, and the common filter is updated to include the data point in the set.
    Type: Application
    Filed: February 12, 2016
    Publication date: February 9, 2017
    Inventor: Henry STERN
  • Parallel detection of updates to a domain name system record system using a common filter
    Patent number: 9264440
    Abstract: In an embodiment, a computer-implemented method detects updates to a domain name system record system. In the method, a stream of data points is received with each data point describing a record of a domain name system. For respective data points, a processor is selected from a plurality of processors. The processors are each configured to apply a data point against a common filter that assesses whether the data point is in a set. At the selected processor, the respective data point is applied to the common filter to determine whether the record is included in the set. When the record is determined not to be included in the set, a message is provided to indicate that the domain name system includes a new record, and the common filter is updated to include the data point in the set.
    Type: Grant
    Filed: August 4, 2015
    Date of Patent: February 16, 2016
    Assignee: FARSIGHT SECURITY, INC.
    Inventor: Henry Stern
  • ANTAGONIST ANTIBODIES DIRECTED AGAINST CALCITONIN GENE-RELATED PEPTIDE AND METHODS USING SAME
    Publication number: 20150322142
    Abstract: The invention features methods for preventing or treating CGRP associated disorders such as vasomotor symptoms and/or headaches (e.g., migraine, cluster headache, and tension headache) by administering an anti-CGRP antagonist antibody. Compositions for use in the disclosed methods are also provided. Antagonist antibody G1 and antibodies derived from G1 directed to CGRP are also described.
    Type: Application
    Filed: May 13, 2015
    Publication date: November 12, 2015
    Inventors: Marcelo BIGAL, Sarah Walter, Henry Stern, Michael Chang
  • ANTAGONIST ANTIBODIES DIRECTED AGAINST CALCITONIN GENE-RELATED PEPTIDE AND METHODS USING SAME
    Publication number: 20150266948
    Abstract: The invention features methods for preventing or treating CGRP associated disorders such as vasomotor symptoms and/or headaches (e.g., migraine, cluster headache, and tension headache) by administering an anti-CGRP antagonist antibody. Compositions for use in the disclosed methods are also provided. Antagonist antibody G1 and antibodies derived from G1 directed to CGRP are also described.
    Type: Application
    Filed: March 20, 2015
    Publication date: September 24, 2015
    Inventors: Marcelo Bigal, Sarah Walter, Henry Stern, Michael Chang
  • Display screen or portion thereof with a graphical user interface
    Patent number: D776133
    Type: Grant
    Filed: June 23, 2015
    Date of Patent: January 10, 2017
    Assignee: Zynga Inc.
    Inventors: Gregory Hill, Henry Stern